Isoflavones Market by Source (Soy, Red Clover, and Others), Application (Pharmaceuticals, Nutraceuticals, Cosmetics, and Food & Beverages), and Form (Powder and Liquid): Global Opportunity Analysis and Industry Forecast 2021–2030
- ALL4676793
- 292 Pages
- August 2021
- Food and Beverages
Isoflavones are a type of nutritional supplement that is almost entirely produced by the Fabaceae, Leguminosae, or bean family. It is a specific group of molecules, also known as a phytochemical, which can be found in foods, such as legumes, and herbs such as red clover. Isoflavones have the potential to protect against age-related diseases such as cardiovascular disease, osteoporosis, hormone-dependent cancer, and cognitive decline.
Isoflavones lower the risk of breast cancer while also inhibiting cancer cell growth by reducing cell multiplication. It is also a good source of antioxidants, which help to protect the cardiovascular system by lowering cholesterol levels. It also lowers the risk of stroke and coronary heart disease. As a result of these advantages, the popularity of isoflavones is growing. The increased use of isoflavones in the cosmetics and food & beverage industries is driving the global demand for isoflavones.
However, side effects, such as thyroid disorders, food allergies, migraine headaches, and increased heart rate after excessive consumption, are limiting the growth of the global isoflavones market. Regulations governing the use of isoflavones in nutraceuticals, nutraceutical cosmetics, and dietary supplements, particularly infant formulas, are extremely stringent in some regions and will pose a challenge to the market players.
The pandemic of COVID-19 has raised consumer awareness of the importance of a healthy diet and supplements. Many dietary supplements and nutraceuticals products consist of isoflavones, which help to build gut health. As a result, the isoflavones market was moderately affected due to the pandemic.
Consumption of isoflavones through food and food supplements also reduces the risk of breast cancer and cancer cell growth by reducing cell mitosis, which boosts the demand for isoflavones from the food & beverages industry and has become a driving factor for the global isoflavones market. The cosmetics industry's increasing demand for isoflavones to treat skin wrinkles, protect skin from sun damage, and moisturize skin drives the global isoflavones market.
The isoflavones market is segmented on the basis of source, application, form, and region. On the basis of source, the market is categorized into soy, red clover, and others. As per application, the market is divided into pharmaceuticals, nutraceuticals, cosmetics, and food & beverages. According to form, the isoflavones market is fragmented into powder and liquid. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, the Netherlands, and the rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and the rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Argentina, Saudi Arabia, and the rest of LAMEA).
Asia-Pacific is witnessing a significant increase in consumer awareness as a result of global players' competitive strategies. Demand from countries, such as India, China, and Australia, is helping to drive the overall growth. The growing population, combined with rising disposable income and living standards, is expected to contribute to the overall growth.
The market is being driven by factors such as rapid growth in the food & beverage industries in developing countries, such as India and China, as well as increased awareness of the benefits of isoflavones products. The major players operating in the global isoflavones market are Cargill, Archer-Daniels-Midland (ADM) Company, Badische Anilin und Soda Fabrik (BASF), DSM, International Flavors and Fragrances, Shanghai Freemen, Nexira Inc., Bio-gen Extracts, Sikko Industries, SK Bioland, BioMax, Herbo Nutra, and NutraScience Labs.
Key benefits for stakeholders
• The report provides a quantitative analysis of the current market, estimations, trends, and dynamics of the global isoflavones market size from 2020 to 2030 to identify the prevailing market opportunities.
• The key countries in all the major regions are mapped based on the market share and market trends.
• Porter’s five forces analysis highlights the potency of the buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier–buyer network.
• In-depth analysis of the market segment and size assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global isoflavones industry.
• Market player positioning segment facilitates benchmarking and provides a clear understanding of the present position of the market players.
Key market segments
By Source
• Soy
• Red Clover
• Others
By Form
• Powder
• Liquid
By Application
• Pharmaceuticals
• Nutraceuticals
• Cosmetics
• Food & Beverages
By Region
North America
o U.S.
o Canada
o Mexico
Europe
o UK
o Germany
o France
o Italy
o Spain
o Netherlands
o Rest of Europe
Asia-Pacific
o China
o Japan
o India
o South Korea
o Australia
o Rest of Asia-Pacific
LAMEA
o Brazil
o South Africa
o Argentina
o Saudi Arabia
o Rest of LAMEA
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Snapshot
2.2.Key findings
2.2.1.Top investment pocket
2.3.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key forces shaping the global isoflavones market
3.2.1.Bargaining power of suppliers
3.2.2.Bargaining power of buyers
3.2.3.Thereat of new entrants
3.2.4.Threat of substitutes
3.2.5.Intensity of competitive rivalry
3.3.Market dynamics
3.3.1.Drivers
3.3.1.1.Rising prevalence of cancer and cardiovascular diseases
3.3.1.2.Prevalence of menopausal issues
3.3.1.3.Rising demand for fortified food owing to increasing health consciousness amongst consumers
3.3.1.4.Rapidly increasing geriatric population
3.3.2.Restraints
3.3.2.1.Stringent regulatory requirements
3.3.2.2.Less efficiency compared to alternatives
3.3.3.Opportunities
3.3.3.1.Emerging markets
3.3.3.2.Emerging technologies
3.3.4.COVID-19 impact analysis
3.3.5.Player positioning
CHAPTER 4:GLOBAL ISOFLAVONES MARKET, BY SOURCE
4.1.Overview
4.1.1.Market size and forecast
4.2.Soy
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast
4.2.3.Market analysis, by country
4.3.Red clover
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country
4.4.Others
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast
4.4.3.Market analysis, by country
CHAPTER 5:GLOBAL ISOFLAVONES MARKET, BY APPLICATION
5.1.Overview
5.1.1.Market size and forecast
5.2.Pharmaceuticals
5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast
5.2.3.Market analysis, by country
5.3.Nutraceuticals
5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast
5.3.3.Market analysis, by country
5.4.Cosmetics
5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast
5.4.3.Market analysis, by country
5.5.Food & beverages
5.5.1.Key market trends, growth factors, and opportunities
5.5.2.Market size and forecast
5.5.3.Market analysis, by country
CHAPTER 6:GLOBAL ISOFLAVONES MARKET, BY FORM
6.1.Overview
6.1.1.Market size and forecast
6.2.Powder
6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast
6.2.3.Market analysis, by country
6.3.Liquid
6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast
6.3.3.Market analysis, by country
CHAPTER 7:ISOFLAVONES MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast, by source
7.2.3.Market size and forecast, by application
7.2.4.Market size and forecast, by form
7.2.5.Market size and forecast, by country
7.2.6.U.S.
7.2.6.1.Market size and forecast, by source
7.2.6.3.Market size and forecast, by application
7.2.6.4.Market size and forecast, by form
7.2.7.Canada
7.2.7.1.Market size and forecast, by source
7.2.7.3.Market size and forecast, by application
7.2.7.4.Market size and forecast, by form
7.2.8.Mexico
7.2.8.1.Market size and forecast, by source
7.2.8.3.Market size and forecast, by application
7.2.8.4.Market size and forecast, by form
7.3.Europe
7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast, by source
7.3.3.Market size and forecast, by application
7.3.4.Market size and forecast, by form
7.3.5.Market size and forecast, by country
7.3.6.UK
7.3.6.1.Market size and forecast, by source
7.3.6.3.Market size and forecast, by application
7.3.6.4.Market size and forecast, by form
7.3.7.Germany
7.3.7.1.Market size and forecast, by source
7.3.7.3.Market size and forecast, by application
7.3.7.4.Market size and forecast, by form
7.3.8.France
7.3.8.1.Market size and forecast, by source
7.3.8.3.Market size and forecast, by application
7.3.8.4.Market size and forecast, by form
7.3.9.Italy
7.3.9.1.Market size and forecast, by source
7.3.9.3.Market size and forecast, by application
7.3.9.4.Market size and forecast, by form
7.3.10.Spain
7.3.10.1.Market size and forecast, by source
7.3.10.3.Market size and forecast, by application
7.3.10.4.Market size and forecast, by form
7.3.11.Netherlands
7.3.11.1.Market size and forecast, by source
7.3.11.3.Market size and forecast, by application
7.3.11.4.Market size and forecast, by form
7.3.12.Rest of Europe
7.3.12.1.Market size and forecast, by source
7.3.12.3.Market size and forecast, by application
7.3.12.4.Market size and forecast, by form
7.4.Asia-Pacific
7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Market size and forecast, by source
7.4.3.Market size and forecast, by application
7.4.4.Market size and forecast, by form
7.4.5.Market size and forecast, by country
7.4.6.China
7.4.6.1.Market size and forecast, by source
7.4.6.3.Market size and forecast, by application
7.4.6.4.Market size and forecast, by form
7.4.7.Japan
7.4.7.1.Market size and forecast, by source
7.4.7.3.Market size and forecast, by application
7.4.7.4.Market size and forecast, by form
7.4.8.India
7.4.8.1.Market size and forecast, by source
7.4.8.3.Market size and forecast, by application
7.4.8.4.Market size and forecast, by form
7.4.9.South Korea
7.4.9.1.Market size and forecast, by source
7.4.9.3.Market size and forecast, by application
7.4.9.4.Market size and forecast, by form
7.4.10.Australia
7.4.10.1.Market size and forecast, by source
7.4.10.3.Market size and forecast, by application
7.4.10.4.Market size and forecast, by form
7.4.11.Rest of Asia-Pacific
7.4.11.1.Market size and forecast, by source
7.4.11.3.Market size and forecast, by application
7.4.11.4.Market size and forecast, by form
7.5.LAMEA
7.5.1.Key market trends, growth factors, and opportunities
7.5.2.Market size and forecast, by source
7.5.3.Market size and forecast, by application
7.5.4.Market size and forecast, by form
7.5.5.Market size and forecast, by country
7.5.6.Brazil
7.5.6.1.Market size and forecast, by source
7.5.6.3.Market size and forecast, by application
7.5.6.4.Market size and forecast, by form
7.5.7.South Africa
7.5.7.1.Market size and forecast, by source
7.5.7.3.Market size and forecast, by application
7.5.7.4.Market size and forecast, by form
7.5.8.Argentina
7.5.8.1.Market size and forecast, by source
7.5.8.3.Market size and forecast, by application
7.5.8.4.Market size and forecast, by form
7.5.9.Saudi Arabia
7.5.9.1.Market size and forecast, by source
7.5.9.3.Market size and forecast, by application
7.5.9.4.Market size and forecast, by form
7.5.10.Rest of LAMEA
7.5.10.1.Market size and forecast, by source
7.5.10.3.Market size and forecast, by application
7.5.10.4.Market size and forecast, by form
CHAPTER 8:COMPETITION LANDSCAPE
8.1.Top winning strategies
8.2.Product mapping
8.3.Competitive dashboard
8.4.Competitive heatmap
8.5.Key developments
8.5.1.Acquisition
8.5.2.Business expansion
8.5.3.Joint venture
CHAPTER 9:COMPANY PROFILES
9.1.Archer-Daniels-Midland Company (ADM)
9.1.1.Company overview
9.1.2.Key executives
9.1.3.Company snapshot
9.1.4.Operating business segments
9.1.5.Product portfolio
9.1.6.R&D expenditure
9.1.7.Business performance
9.1.8.Key strategic moves and developments
9.2.BASF SE
9.2.1.Company overview
9.2.2.Key executives
9.2.3.Company snapshot
9.2.4.Operating business segments
9.2.5.Product portfolio
9.2.6.Business performance
9.3.Biomax Life Sciences Limited
9.3.1.Company overview
9.3.2.Key executives
9.3.3.Company snapshot
9.3.4.Product portfolio
9.4.Cargill, Inc.
9.4.1.Company overview
9.4.2.Key executives
9.4.3.Company snapshot
9.4.4.Operating business segments
9.4.5.Product portfolio
9.4.6.Business performance
9.4.7.Key strategic moves and developments
9.5.DSM
9.5.1.Company overview
9.5.2.Key executives
9.5.3.Company snapshot
9.5.4.Operating business segments
9.5.5.Product portfolio
9.5.6.R&D expenditure
9.5.7.Business performance
9.6.Herbo Nutra
9.6.1.Company overview
9.6.2.Key executives
9.6.3.Company snapshot
9.6.4.Product portfolio
9.7.International Flavors and Fragrances
9.7.1.Company overview
9.7.2.Key executives
9.7.3.Company snapshot
9.7.4.Operating business segments
9.7.5.Product portfolio
9.7.6.R&D expenditure
9.7.7.Business performance
9.7.8.Key strategic moves and developments
9.8.Nexira Inc
9.8.1.Company overview
9.8.2.Key executives
9.8.3.Company snapshot
9.8.4.Product portfolio
9.9.NutraScience Labs
9.9.1.Company overview
9.9.2.Key executives
9.9.3.Company snapshot
9.9.4.Product portfolio
9.9.5.Business performance
9.9.6.Key strategic moves and developments
9.10.Shanghai Freemen
9.10.1.Company overview
9.10.2.Key executives
9.10.3.Company snapshot
9.10.4.Product portfolio
TABLE 01.GLOBAL ISOFLAVONES, MARKET BY SOURCE, 2020–2030 ($MILLION)
TABLE 02.SOY ISOFLAVONES MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 03.RED CLOVER ISOFLAVONES MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 04.OTHERS ISOFLAVONES MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 05.GLOBAL ISOFLAVONES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 06.ISOFLAVONES MARKET FOR PHARMACEUTICALS, BY REGION, 2020–2030 ($MILLION)
TABLE 07.ISOFLAVONES MARKET FOR NUTRACEUTICALS, BY REGION, 2020–2030 ($MILLION)
TABLE 08.ISOFLAVONES MARKET FOR COSMETICS, BY REGION, 2020–2030 ($MILLION)
TABLE 09.ISOFLAVONES MARKET FOR FOOD & BEVERAGES, BY REGION, 2020–2030 ($MILLION)
TABLE 10.GLOBAL ISOFLAVONES MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 11.POWDER ISOFLAVONES MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 12.LIQUID ISOFLAVONES MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 13.GLOBAL ISOFLAVONES MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 14.NORTH AMERICA ISOFLAVONES MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 15.NORTH AMERICA ISOFLAVONES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 16.NORTH AMERICA ISOFLAVONES MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 17.NORTH AMERICA ISOFLAVONES MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 18.U.S. ISOFLAVONES MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 19.U.S. ISOFLAVONES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 20.U.S. ISOFLAVONES MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 21.CANADA ISOFLAVONES MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 22.CANADA ISOFLAVONES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 23.CANADA ISOFLAVONES MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 24.MEXICO ISOFLAVONES MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 25.MEXICO ISOFLAVONES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 26.MEXICO ISOFLAVONES MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 27.EUROPE ISOFLAVONES MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 28.EUROPE ISOFLAVONES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 29.EUROPE ISOFLAVONES MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 30.EUROPE ISOFLAVONES MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 31.UK ISOFLAVONES MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 32.UK ISOFLAVONES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 33.UK ISOFLAVONES MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 34.GERMANY ISOFLAVONES MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 35.GERMANY ISOFLAVONES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 36.GERMANY ISOFLAVONES MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 37.FRANCE ISOFLAVONES MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 38.FRANCE ISOFLAVONES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 39.FRANCE ISOFLAVONES MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 40.ITALY ISOFLAVONES MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 41.ITALY ISOFLAVONES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 42.ITALY ISOFLAVONES MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 43.SPAIN ISOFLAVONES MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 44.SPAIN ISOFLAVONES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 45.SPAIN ISOFLAVONES MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 46.NETHERLANDS ISOFLAVONES MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 47.NETHERLANDS ISOFLAVONES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 48.NETHERLANDS ISOFLAVONES MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 49.REST OF EUROPE ISOFLAVONES MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 50.REST OF EUROPE ISOFLAVONES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 51.REST OF EUROPE ISOFLAVONES MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 52.ASIA-PACIFIC ISOFLAVONES MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 53.ASIA-PACIFIC ISOFLAVONES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 54.ASIA-PACIFIC ISOFLAVONES MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 55.ASIA-PACIFIC ISOFLAVONES MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 56.CHINA ISOFLAVONES MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 57.CHINA ISOFLAVONES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 58.CHINA ISOFLAVONES MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 59.JAPAN ISOFLAVONES MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 60.JAPAN ISOFLAVONES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 61.JAPAN ISOFLAVONES MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 62.INDIA ISOFLAVONES MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 63.INDIA ISOFLAVONES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 64.INDIA ISOFLAVONES MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 65.SOUTH KOREA ISOFLAVONES MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 66.SOUTH KOREA ISOFLAVONES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 67.SOUTH KOREA ISOFLAVONES MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 68.AUSTRALIA ISOFLAVONES MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 69.AUSTRALIA ISOFLAVONES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 70.AUSTRALIA ISOFLAVONES MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 71.REST OF ASIA-PACIFIC ISOFLAVONES MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 72.REST OF ASIA-PACIFIC ISOFLAVONES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 73.REST OF ASIA-PACIFIC ISOFLAVONES MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 74.LAMEA ISOFLAVONES MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 75.LAMEA ISOFLAVONES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 76.LAMEA ISOFLAVONES MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 77.LAMEA ISOFLAVONES MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 78.BRAZIL ISOFLAVONES MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 79.BRAZIL ISOFLAVONES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 80.BRAZIL ISOFLAVONES MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 81.SOUTH AFRICA ISOFLAVONES MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 82.SOUTH AFRICA ISOFLAVONES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 83.SOUTH AFRICA ISOFLAVONES MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 84.ARGENTINA ISOFLAVONES MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 85.ARGENTINA ISOFLAVONES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 86.ARGENTINA ISOFLAVONES MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 87.SAUDI ARABIA ISOFLAVONES MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 88.SAUDI ARABIA ISOFLAVONES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 89.SAUDI ARABIA ISOFLAVONES MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 90.REST OF LAMEA ISOFLAVONES MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 91.REST OF LAMEA ISOFLAVONES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 92.REST OF LAMEA ISOFLAVONES MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 93.ADM: KEY EXECUTIVES
TABLE 94.ADM: COMPANY SNAPSHOT
TABLE 95.ADM: OPERATING SEGMENTS
TABLE 96.ADM: PRODUCT PORTFOLIO
TABLE 97.ADM: R&D EXPENDITURE, 2018–2020 ($MILLION)
TABLE 98.ADM: NET SALES, 2018–2020 ($MILLION)
TABLE 99.KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 100.BASF SE: KEY EXECUTIVES
TABLE 101.BASF SE: COMPANY SNAPSHOT
TABLE 102.BASF SE: OPERATING SEGMENTS
TABLE 103.BASF SE: PRODUCT PORTFOLIO
TABLE 104.BASF SE: NET SALES, 2018–2020 ($MILLION)
TABLE 105.BIOMAX LIFE SCIENCES LIMITED: KEY EXECUTIVES
TABLE 106.BIOMAX LIFE SCIENCES LIMITED: COMPANY SNAPSHOT
TABLE 107.BIOMAX LIFE SCIENCES LIMITED: PRODUCT PORTFOLIO
TABLE 108.CARGILL, INC.: KEY EXECUTIVES
TABLE 109.CARGILL, INC.: COMPANY SNAPSHOT
TABLE 110.CARGILL, INC.: OPERATING SEGMENTS
TABLE 111.CARGILL, INC.: PRODUCT PORTFOLIO
TABLE 112.CARGILL, INC.: NET SALES, 2018–2020 ($MILLION)
TABLE 113.KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 114.DSM: KEY EXECUTIVES
TABLE 115.DSM: COMPANY SNAPSHOT
TABLE 116.DSM: OPERATING SEGMENTS
TABLE 117.DSM: PRODUCT PORTFOLIO
TABLE 118.DSM: R&D EXPENDITURE, 2018–2020 ($MILLION)
TABLE 119.DSM: NET SALES, 2018–2020 ($MILLION)
TABLE 120.HERBO NUTRA: KEY EXECUTIVES
TABLE 121.HERBO NUTRA: COMPANY SNAPSHOT
TABLE 122.HERBO NUTRA: PRODUCT PORTFOLIO
TABLE 123.INTERNATIONAL FLAVORS AND FRAGRANCES: KEY EXECUTIVES
TABLE 124.INTERNATIONAL FLAVORS AND FRAGRANCES: COMPANY SNAPSHOT
TABLE 125.INTERNATIONAL FLAVORS AND FRAGRANCES: OPERATING SEGMENTS
TABLE 126.INTERNATIONAL FLAVORS AND FRAGRANCES: PRODUCT PORTFOLIO
TABLE 127.INTERNATIONAL FLAVORS AND FRAGRANCES: R&D EXPENDITURE, 2018–2020 ($MILLION)
TABLE 128.INTERNATIONAL FLAVORS AND FRAGRANCES: NET SALES, 2018–2020 ($MILLION)
TABLE 129.KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 130.NEXIRA INC: KEY EXECUTIVES
TABLE 131.NEXIRA INC: COMPANY SNAPSHOT
TABLE 132.NEXIRA INC: PRODUCT PORTFOLIO
TABLE 133.NUTRASCIENCE LABS: KEY EXECUTIVES
TABLE 134.NUTRASCIENCE LABS: COMPANY SNAPSHOT
TABLE 135.NUTRASCIENCE LABS: PRODUCT PORTFOLIO
TABLE 136.NUTRASCIENCE LABS: NET SALES, 2018–2020 ($MILLION)
TABLE 137.KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 138.SHANGHAI FREEMEN: KEY EXECUTIVES
TABLE 139.SHANGHAI FREEMEN: COMPANY SNAPSHOT
TABLE 140.SHANGHAI FREEMEN: PRODUCT PORTFOLIO
Similar Reports
Driven by improving living standards of people and a fast-growing macro-economy, China has remained the largest beer-consuming country worldwide for the 12th consecutive year since 2003, and the largest beer-producing nation globally in the past years. This report focuses on systematic evaluation and analysis of Internal Risks (arising within the industry development itself) and External Risks (ar...
- Publish Date: November 26, 2014
- $800
Summary Based on products type, the report describes major products type share of regional market. Products mentioned as follows: By Type Microparticulated Protein Modified Whey Protein Concentrate Others Based on region, the report describes major regions market by vendor, products and application. Regions mentioned as follows: North America Europe Asia RoW Based on application, the repor...
- Publish Date: March 1, 2017
- $840
Summary The global Oat Protein market is estimated to reach 1.4 K MT in 2017. The objective of report is to define, segment, and project the market on the basis of type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc. Based on products type, the report describes major products type share of regio...
- Publish Date: April 15, 2017
- $840
